Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED)

NCT00705263 · clinicaltrials.gov ↗

COMPLETED

Status

113

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic
Hepacivirus

Interventions

BIOLOGICAL: Peginterferon alfa-2b (SCH 54031)
DRUG: Ribavirin (SCH 18908)

Sponsor

Schering-Plough